50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
"White Gold" is the New Oil (Ad)
SunPower Is Ready To Power Up Triple-Digit Earnings Gains
Build A Better Tech Portfolio With Jabil Inc.
"White Gold" is the New Oil (Ad)
US stocks end mixed a day after Dow entered a bear market
Leaks on Russian gas pipelines raise concerns about sabotage
Is the US Military Secretly Under Chinese Control? (Ad)
Will UPS Be Next to Deliver a Warning?
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
"White Gold" is the New Oil (Ad)
SunPower Is Ready To Power Up Triple-Digit Earnings Gains
Build A Better Tech Portfolio With Jabil Inc.
"White Gold" is the New Oil (Ad)
US stocks end mixed a day after Dow entered a bear market
Leaks on Russian gas pipelines raise concerns about sabotage
Is the US Military Secretly Under Chinese Control? (Ad)
Will UPS Be Next to Deliver a Warning?
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
"White Gold" is the New Oil (Ad)
SunPower Is Ready To Power Up Triple-Digit Earnings Gains
Build A Better Tech Portfolio With Jabil Inc.
"White Gold" is the New Oil (Ad)
US stocks end mixed a day after Dow entered a bear market
Leaks on Russian gas pipelines raise concerns about sabotage
Is the US Military Secretly Under Chinese Control? (Ad)
Will UPS Be Next to Deliver a Warning?
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
"White Gold" is the New Oil (Ad)
SunPower Is Ready To Power Up Triple-Digit Earnings Gains
Build A Better Tech Portfolio With Jabil Inc.
"White Gold" is the New Oil (Ad)
US stocks end mixed a day after Dow entered a bear market
Leaks on Russian gas pipelines raise concerns about sabotage
Is the US Military Secretly Under Chinese Control? (Ad)
Will UPS Be Next to Deliver a Warning?
Vote in Ukraine's Russia-held areas stokes tension with West
NASDAQ:GOSS

Gossamer Bio - GOSS Stock Forecast, Price & News

$12.41
+0.36 (+2.99%)
(As of 09/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$12.09
$12.52
50-Day Range
$11.17
$14.88
52-Week Range
$5.64
$15.19
Volume
1.03 million shs
Average Volume
1.03 million shs
Market Capitalization
$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.10

Gossamer Bio MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
53.9% Upside
$19.10 Price Target
Short Interest
Bearish
22.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.67mentions of Gossamer Bio in the last 14 days
Based on 11 Articles This Week
Insider Trading
Acquiring Shares
$1.15 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.77) to ($2.58) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

204th out of 1,071 stocks

Pharmaceutical Preparations Industry

78th out of 531 stocks

GOSS stock logo

About Gossamer Bio (NASDAQ:GOSS) Stock

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Receive GOSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter.

GOSS Stock News Headlines

Peaking Back In On Gossamer Bio
Gossamer Bio (NASDAQ:GOSS) Shares Gap Down to $13.60
JPMorgan Chase & Co. Initiates Coverage on Gossamer Bio (NASDAQ:GOSS)
1GOSS : Where Gossamer Bio Stands With Analysts
What 4 Analyst Ratings Have To Say About Gossamer Bio
Gossamer Bio (GOSS) Investor Presentation - Slideshow
Analyst Ratings for Gossamer Bio
See More Headlines
Receive GOSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter.

GOSS Company Calendar

Last Earnings
8/09/2022
Today
9/27/2022
Next Earnings (Estimated)
11/14/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GOSS
Fax
N/A
Employees
185
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.10
High Stock Price Forecast
$24.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+53.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$-234,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.59 per share

Miscellaneous

Free Float
86,156,000
Market Cap
$1.17 billion
Optionable
Not Optionable
Beta
0.92

Key Executives

  • Mr. Faheem Hasnain (Age 64)
    Co-Founder, CEO, Pres & Chairman
    Comp: $895.56k
  • Mr. Bryan GiraudoMr. Bryan Giraudo (Age 47)
    COO & CFO
    Comp: $651.8k
  • Mr. Christian Waage (Age 55)
    Exec. VP of Technical Operations & Admin.
    Comp: $583.16k
  • Dr. Laura L. Carter Ph.D. (Age 55)
    Chief Scientific Officer
  • Mr. Jeff Boerneke
    Gen. Counsel & Sec.
  • Ms. Deanna Weber
    Sr. VP of HR
  • Dr. Richard Aranda M.D. (Age 62)
    Chief Medical Officer
  • Mr. Mario Orlando
    Sr. VP of Commercial New Product Planning
  • Ms. Caryn L. Peterson (Age 63)
    Exec. VP of Regulatory Affairs
  • Mr. Matt Cravets
    Sr. VP of Biometrics













GOSS Stock - Frequently Asked Questions

Should I buy or sell Gossamer Bio stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Gossamer Bio in the last year. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" GOSS shares.
View GOSS analyst ratings
or view top-rated stocks.

What is Gossamer Bio's stock price forecast for 2022?

10 Wall Street research analysts have issued 1 year price objectives for Gossamer Bio's stock. Their GOSS share price forecasts range from $14.00 to $24.00. On average, they expect the company's stock price to reach $19.10 in the next twelve months. This suggests a possible upside of 53.9% from the stock's current price.
View analysts price targets for GOSS
or view top-rated stocks among Wall Street analysts.

How have GOSS shares performed in 2022?

Gossamer Bio's stock was trading at $11.31 on January 1st, 2022. Since then, GOSS stock has increased by 9.7% and is now trading at $12.41.
View the best growth stocks for 2022 here
.

When is Gossamer Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our GOSS earnings forecast
.

How were Gossamer Bio's earnings last quarter?

Gossamer Bio, Inc. (NASDAQ:GOSS) released its quarterly earnings results on Tuesday, August, 9th. The company reported ($0.74) earnings per share for the quarter, missing the consensus estimate of ($0.67) by $0.07.

What other stocks do shareholders of Gossamer Bio own?
When did Gossamer Bio IPO?

(GOSS) raised $230 million in an initial public offering on Friday, February 8th 2019. The company issued 14,400,000 shares at $16.00 per share. BofA Merrill Lynch, Leerink Partners, Barclays and Evercore ISI acted as the underwriters for the IPO.

What is Gossamer Bio's stock symbol?

Gossamer Bio trades on the NASDAQ under the ticker symbol "GOSS."

Who are Gossamer Bio's major shareholders?

Gossamer Bio's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State Street Corp (4.12%), Emerald Advisers LLC (2.42%), Palo Alto Investors LP (1.86%), Millennium Management LLC (1.58%), Woodline Partners LP (1.20%) and Point72 Asset Management L.P. (1.03%). Insiders that own company stock include Bryan Giraudo, Caryn Peterson, Faheem Hasnain, Jakob Dupont, Laura Carter, Luisa Salter-Cid, Richard Aranda and Waage Christian.
View institutional ownership trends
.

How do I buy shares of Gossamer Bio?

Shares of GOSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Gossamer Bio's stock price today?

One share of GOSS stock can currently be purchased for approximately $12.41.

How much money does Gossamer Bio make?

Gossamer Bio (NASDAQ:GOSS) has a market capitalization of $1.17 billion. The company earns $-234,000,000.00 in net income (profit) each year or ($3.04) on an earnings per share basis.

How many employees does Gossamer Bio have?

The company employs 185 workers across the globe.

How can I contact Gossamer Bio?

Gossamer Bio's mailing address is 3013 SCIENCE PARK, SAN DIEGO CA, 92121. The official website for the company is www.gossamerbio.com. The company can be reached via phone at (858) 684-1300 or via email at ir@gossamerbio.com.

This page (NASDAQ:GOSS) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.